Anest. intenziv. Med. 2007;18(6):324-327

Advances in general anaesthesiaAnaesthesiology

J. Málek
Klinika anesteziologie a resuscitace 3. LF UK a FNKV, Praha

In 2006-2007 we celebrated the160th anniversary of the first successful administrations of general inhalational anaesthesia in various countries and the 50th anniversary of the publication of the mouth-to-mouth ventilation method by Dr. Safar.There have been no significant developments in general anaesthesia in the past two years. Perhaps the most cited single drug was sugammadex and the issue of residual neuromuscular blockade. Another interesting topic was the potential neurotoxicity of general anaesthetics. At the end of the article, a list of reviews is given.

Keywords: general anaesthesia; sugammadex; anaesthetics; neurotoxicity; reviews

Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Málek J. Advances in general anaesthesia. Anest. intenziv. Med. 2007;18(6):324-327.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Poulsen, H., Hougs, W. The effect of some curarizing drugs in unanaesthetized man. I. d-Tubocurarine chloride, gallamonium iodide, decamethonium iodide, succinylcholine iodide and its bis-monoethyl-substituted derivative in single or repeated doses. Acta Anaesth. Scand., 2007, 51, p. 1018-1042. Go to original source... Go to PubMed...
    2. Lind, B. The birth of the resuscitation mannequin, Resusci Anne, and the teaching of mouth-to-mouth ventilation. Acta Anaest. Scand, 2007, 51, p. 1051-1053. Go to original source... Go to PubMed...
    3. Kilpatrick, G. J., Tilbrook, G. S. Drug development in anaesthesia: industrial perspective. Curr. Opin. Anaesthesiol., 2006, 19, p. 385-389. Go to original source... Go to PubMed...
    4. Herold, I. Myorelaxancia po 65 letech - kam směřuje další výzkum? In Cvachovec, K., Černý, V. (eds.) Novinky v anesteziologii, intenzivní medicíně a léčbě bolesti. Praha : Galén 2007, p. 141-144.
    5. Adamus, M. Pooperační reziduální kurarizace (PORC) - nikdy nekončící příběh z pohledu medicíny založené na důkazech. In Cvachovec, K., Černý, V. (eds.) Novinky v anesteziologii, intenzivní medicíně a léčbě bolesti. Praha : Galén 2007, p. 145-151.
    6. Schreiber, J. U., Fuchs-Buder, T. Neuromuscular blockades. Agents, monitoring and antagonism. Anaesthesist, 2006, 55, p. 1225-1235. Go to original source... Go to PubMed...
    7. Fuchs-Buder, T., Eikermann, M. Residual neuromuscular blockades. Clinical consequences, frequency and avoidance strategies. Anaesthesist, 2006, 55, p. 7-16. Go to original source... Go to PubMed...
    8. Viby-Mogensen, J., Claudius, C., Eriksson, L. I. Neuromuscular monitoring and postoperative residual curarization. Br. J. Anaesth., 2007, 99, p. 297. Go to original source... Go to PubMed...
    9. Adamus, M., Koutna, J., Neoral, C. The incidence of postoperative residual curarization in the recovery room after rocuronium administration. Rozhl. Chir, 2007, 86, p. 11-16. Go to PubMed...
    10. Bettelli, G. Which muscle relaxants should be used in day surgery and when. Curr. Opin. Anaesthesiol., 2006, 19, p. 600-605. Go to original source... Go to PubMed...
    11. Sorgenfrei, I. F., Viby-Mogensen, J., Swiatek, F. A. Does evidence lead to a change in clinical practice? Danish anaesthetists' and nurse anesthetists' clinical practice and knowledge of postoperative residual curarization. Ugeskr. Laeger., 2005, 167, p. 3878-3882. Go to PubMed...
    12. Jones, P. M., Turkstra, T. P. Urgent usage of sugammadex to treat residual neuromuscular blockade in the PACU. Anesth. Analg., 2007, 105, p. 877. Go to original source... Go to PubMed...
    13. de Boer, H. D., Driessen, J. J., Marcus, M. A. et al. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology, 2007, 107, p. 239-244. Go to original source... Go to PubMed...
    14. Nicholson, W. T., Sprung, J., Jankowski, C. J. Sugammadex: a novel agent for the reversal of neuromuscular blockade. Pharmacotherapy, 2007, 27, p. 1181-1188. Go to original source... Go to PubMed...
    15. Fields, A. M., Vadivelu, N. Sugammadex: a novel neuromuscular blocker binding agent. Curr. Opin. Anaesthesiol., 2007, 20, p. 307-310. Go to original source... Go to PubMed...
    16. Sparr, H. J., Vermeyen, K. M., Beaufort, A. M. et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology, 2007, 106, p. 935-943. Go to original source... Go to PubMed...
    17. Molina, A. L., de Boer, H. D., Klimek, M. et al. Reversal of rocuronium-induced (1.2 mg. kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg.kg-1). Br. J. Anaesth., 2007, 98, p. 624-627. Go to original source... Go to PubMed...
    18. Lenz, A., Hill, G., White, P. F. Emergency use of sugammadex after failure of standard reversal drugs. Anesth. Analg., 2007, 104, p. 585-586. Go to original source... Go to PubMed...
    19. Naguib, M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth. Analg., 2007, 104, p. 575-581. Go to original source... Go to PubMed...
    20. Sacan, O., White, P. F., Tufanogullari, B., Klein, K. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Anesth. Analg., 2007, 104, p. 569-574. Go to original source... Go to PubMed...
    21. Vanacker, B. F., Vermeyen, K. M., Struys, M. M. et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth. Analg., 2007, 104, p. 563-568. Go to original source... Go to PubMed...
    22. Miller, R. D. Sugammadex: an opportunity to change the practice of anesthesiology? Anesth. Analg., 2007, 104, p. 477-478. Go to original source... Go to PubMed...
    23. Suy, K., Morias, K., Cammu, G. et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology, 2007, 106, p. 283-288. Go to original source... Go to PubMed...
    24. Hunter, J. M., Flockton, E. A. The doughnut and the hole: a new pharmacological concept for anaesthetists. Br. J. Anaesth., 2006, 97, p. 123-126. Go to original source... Go to PubMed...
    25. Sorgenfrei, I. F., Norrild, K., Larsen, P. B. et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology, 2006, 104, p. 667-674. Go to original source... Go to PubMed...
    26. Kopman, A. F. Sugammadex: a revolutionary approach to neuromuscular antagonism. Anesthesiology, 2006, 104, p. 631-633. Go to original source... Go to PubMed...
    27. Shields, M., Giovannelli, M., Mirakhur, R.K. et al. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br. J. Anaesth., 2006, 96, p. 36-43. Go to original source... Go to PubMed...
    28. Eleveld, D. J., Kuizenga, K., Proost, J. H., Wierda, J. M. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex. Anesth. Analg., 2007, 104, p. 582-584. Go to original source... Go to PubMed...
    29. Martyn, J., Durieux, M. E. Succinylcholine: new insights into mechanisms of action of an old drug. Anesthesiology, 2006, 104, p. 633-634. Go to original source... Go to PubMed...
    30. Martyn, J. A., Richtsfeld, M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology, 2006, 104, p. 158-169. Go to original source... Go to PubMed...
    31. Jonsson, M., Dabrowski, M., Gurley, D. A. et al. Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology, 2006, 104, p. 724-733. Go to original source... Go to PubMed...
    32. Stadnicka, A., Marinovic, J., Ljubkovic, M. et al. Volatile anesthetic-induced cardiac preconditioning. J. Anesth., 2007, 21, p. 212-219. Go to original source... Go to PubMed...
    33. Culley, D. J., Xie, Z., Crosby, G. General anesthetic-induced neurotoxicity: an emerging problem for the young and old? Curr. Opin. Anaesthesiol., 2007, 20, p. 408-413. Go to original source... Go to PubMed...
    34. Perouansky, M. Liaisons dangereuses? General anaesthetics and long-term toxicity in the CNS. Eur. J. Anaesthesiol., 2007, 24, p. 107-115. Go to original source... Go to PubMed...
    35. Rowe, R. Neurotoxicity of anesthetic agents in children. Anesth. Analg., 2007, 105, p. 882. Go to original source... Go to PubMed...
    36. Lin, C. Y., Guo, W. Y., Chen, S. P. et al. Neurotoxicity of nitrous oxide: multimodal evoked potentials in an abuser. Clin. Toxicol., 2007, 45, p. 67-71. Go to original source... Go to PubMed...
    37. Gasconm, E., Klauser, P., Kiss, J. Z., Vutskits, L. Potentially toxic effects of anaesthetics on the developing central nervous system. Eur. J. Anaesthesiol., 2007, 24, p. 213-224. Go to original source... Go to PubMed...
    38. Al-Jahdari, W. S., Saito, S., Nakano, T., Goto, F. Propofol induces growth cone collapse and neurite retractions in chick explant culture. Can. J. Anaesth., 2006, 53, p. 1078-1085. Go to original source... Go to PubMed...
    39. El-Beheiry, H., Kavanagh, B. Is propofol neurotoxic to the developing brain? Can. J. Anaesth., 2006, 53, p. 1069-1073. Go to original source... Go to PubMed...
    40. Jevtovic-Todorovic, V., Carter, L. B. The anesthetics nitrous oxide and ketamine are more neurotoxic to old than to young rat brain. Neurobiol. Aging., 2005, 26, p. 947-956. Go to original source... Go to PubMed...
    41. Vutskits, L., Gascon, E., Kiss, J. Z. Effects of ketamine on the developing central nervous system. Ideggyogy Sz., 2007, 60, p. 109-112.
    42. Anand, K. J. Anesthetic neurotoxicity in newborns: should we change clinical practice? Anesthesiology, 2007, 107, p. 2-4. Go to original source... Go to PubMed...
    43. Newman, S., Stygall, J., Hirani, S. et al. Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology, 2007, 106, p. 572-590. Go to original source... Go to PubMed...
    44. Wei, H., Liang, G., Yang, H. Isoflurane preconditioning inhibited isoflurane-induced neurotoxicity. Neurosci. Lett., 2007, 425, p. 59-62. Go to original source... Go to PubMed...
    45. Engelhard, K., Winkelheide, U., Werner, C. et al. Sevoflurane affects neurogenesis after forebrain ischemia in rats. Anesth. Analg., 2007, 104, p. 898-903. Go to original source... Go to PubMed...
    46. Abraini, J. H., David, H. N., Lemaire, M. Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann. N Y Acad. Sci., 2005, 1053, p. 289-300. Go to original source... Go to PubMed...
    47. Head, B. P., Patel, P. Anesthetics and brain protection. Curr. Opin. Anaesthesiol., 2007, 20, p. 395-399. Go to original source... Go to PubMed...
    48. Minguet, G., Joris, J., Lamy, M. Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics? Eur. J. Anaesthesiol., 2007, 24, p. 733-745. Go to original source... Go to PubMed...
    49. Lucchinetti, E., Ambrosio, S., Aguirre, J. et al. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology, 2007, 106, p. 262-268. Go to original source... Go to PubMed...
    50. Steiger, H. J., Hanggi, D. Ischaemic preconditioning of the brain, mechanisms and applications. Acta Neurochir., 2007, 149, p. 1-10. Go to original source... Go to PubMed...
    51. Myles, P. S., Leslie, K., Chan, M. T. et al. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology, 2007, 107, p. 221-231. Go to original source... Go to PubMed...
    52. Kam, P. C., Cardone, D. Propofol infusion syndrome. Anaesthesia, 2007, 62, p. 690-701. Go to original source... Go to PubMed...
    53. Westhout, F. D., Muhonen, M. G., Nwagwu, C. I. Early propofol infusion syndrome following cerebral angiographic embolization for giant aneurysm repair. Case report. J. Neurosurg., 2007, 106, p. 139-142. Go to original source... Go to PubMed...
    54. Sabsovich, I., Rehman, Z., Yunen, J., Coritsidis, G. Propofol infusion syndrome: a case of increasing morbidity with traumatic brain injury. Am. J. Crit. Care, 2007, 16, p. 82-85. Go to original source... Go to PubMed...
    55. De Waele, J. J., Hoste, E. Propofol infusion syndrome in a patient with sepsis. Anaesth. Intensive Care, 2006, 34, p. 676-677. Go to original source... Go to PubMed...
    56. Trampitsch, E., Oher, M., Pointner, I. et al. Propofol infusion syndrome. Anaesthesist, 2006, 55, p. 1166-1168. Go to original source... Go to PubMed...
    57. Fudickar, A., Bein, B., Tonner, P. H. Propofol infusion syndrome in anaesthesia and intensive care medicine. Curr. Opin. Anaesthesiol., 2006, 19, p. 404-410. Go to original source... Go to PubMed...
    58. Kumar, M. A., Urrutia, V. C., Thomas, C. E. et al. The syndrome of irreversible acidosis after prolonged propofol infusion. Neurocrit. Care, 2005, 3, p. 257-259. Go to original source... Go to PubMed...
    59. Liolios, A., Guerit, J. M., Scholtes, J. L. et al. Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult. Anesth. Analg., 2005, 100, p. 1804-1806. Go to original source... Go to PubMed...
    60. Ahlen, K., Buckley, C. J., Goodale, D. B., Pulsford, A. H. The propofol infusion syndrome: the facts, their interpretation and implications for patient care. Eur. J. Anaesthesiol., 2006, 23, p. 990-998. Go to original source... Go to PubMed...
    61. Brill, S., Ginosar, Y., Davidson, E. M. Perioperative management of chronic pain patients with opioid dependency. Curr. Opin. Anaesthesiol., 2006, 19, p. 325-331. Go to original source... Go to PubMed...
    62. Mehta, V., Langford, R. M. Acute pain management for opioid dependent patients. Anaesthesia, 2006, 61, p. 269-276. Go to original source... Go to PubMed...
    63. Huyse, F. J., Touw, D. J., van Schijndel, R. S. et al. Psychotropic drugs and the perioperative period: a proposal for a guideline in elective surgery. Psychosomatics, 2006, 47, p. 8-22. Go to original source... Go to PubMed...
    64. Langeron, O., Amour, J., Vivien, B., Aubrun, F. Clinical review: management of difficult airways. Crit. Care, 2006, 10, p. 243. Go to original source... Go to PubMed...
    65. Gerlach, K., Dorges, V., Uhlig, T. Difficult airway management. Anasthesiol. Intensivmed. Notfallmed. Schmerzther, 2006, 41, s. 93-118. Go to original source... Go to PubMed...
    66. Kranke, P., Eberhart, L. H., Gan, T. J. et al. Algorithms for the prevention of postoperative nausea and vomiting: an efficacy and efficiency simulation. Eur. J. Anaesthesiol., 2007, 24, p. 856-867. Go to original source... Go to PubMed...
    67. Hemmerling, T. M., Le, N. Brief review: Neuromuscular monitoring: an update for the clinician. Can. J. Anaesth., 2007, 54, p. 58-72. Go to original source... Go to PubMed...
    68. Pasternak, J. J., Lanier, W. L. Neuroanesthesiology review - 2006. J. Neurosurg. Anesthesiol., 2007, 19, p. 70-92. Go to original source... Go to PubMed...
    69. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology, 2007, 106, p. 843-863. Go to PubMed...
    70. Allen, M. Pacemakers and implantable cardioverter defibrillators. Anaesthesia, 2006, 61, s. 883-890. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.